Several reports have appeared that suggest that 24,25-dihydroxycholecalciferol has a possible biological role in bone formation. We have utilized competition studies, saturation analysis, sucrose-density-gradient sedimentation and DEAE-cellulose chromatography to demonstrate that long bones of vitamin D-depleted newborn rats contain cytoplasmic and possibly nuclear receptors that bind 24,25-dihydroxycholecalciferol with specificity and high affinity (Kd = 1.79nM). Sucrose-densitygradient analysis of the cytoplasmic 24,25-dihydroxycholecalciferol-binding component showed a single binding macromolecule for 24,25-dihydroxycholecalciferol with a sedimentation coefficient of 3.1 S. DEAE-cellulose chromatography showed a
Several reports have appeared that suggest that 24,25-dihydroxycholecalciferol has a possible biological role in bone formation. We have utilized competition studies, saturation analysis, sucrose-density-gradient sedimentation and DEAE-cellulose chromatography to demonstrate that long bones of vitamin D-depleted newborn rats contain cytoplasmic and possibly nuclear receptors that bind 24,25-dihydroxycholecalciferol with specificity and high affinity (Kd = 1.79nM). Sucrose-densitygradient analysis of the cytoplasmic 24,25-dihydroxycholecalciferol-binding component showed a single binding macromolecule for 24,25-dihydroxycholecalciferol with a sedimentation coefficient of 3.1 S. DEAE-cellulose chromatography showed a
[3H]24,25-dihydroxycholecalciferol-macromolecular complex that binds to DEAEcellulose and elutes between 0.15 and 0.21 M-KCI. The finding of 24,25-dihydroxycholecalciferol receptors in long bones of newborn rats suggests a possible involvement of 24,25-dihydroxycholecalciferol in the metabolism of developing skeletal tissues.
1a,25-Dihydroxycholecalciferol, the active form of vitamin D (De Luca, 1976) , like other steroid hormones, initiates its action by binding to cytoplasmic receptors in target cells. A cytoplasmic receptor for 1a,25-dihydroxycholecalciferol was first described in the intestinal mucosa (Tsai & Norman, 1973; Brumbaugh & Haussler, 1974) . Similar receptor-like binding proteins have been identified in other tissues including bone (Kream et al., 1977a,b; Manolagas et al., 1979; Mellon & De Luca, 1980) , kidney (Chandler et al., 1979) , parathyroid gland , pituitary (Haussler et al., 1980) and pancreas (Christakos & Norman, 1979) . 24,25-Dihydroxycholecalciferol, another metabolite of vitamin D, has possible physiological functions in the formation of endochondral bone (Ornoy et al., 1978; Endo et al., 1980) . Moreover, a specific nuclear binding of 24,25-dihydroxycholecalciferol has been demonstrated in cultured growth-plate chondrocytes (Corvol et al., 1980 (Eisman et al., 1976; Weisman et al., 1977 Tris/HCl buffer, pH 7.4, containing 250mM-sucrose, 50mM-dithiothreitol, 1.5 mM-EGTA and 3mM-MgCI2) in a motor-driven glass/Teflon homogenizer (for the duodenum) or a conical ground-glass homogenizer (for the tibiae). The homogenates were centrifuged at 800g for 10min at 40C to yield a nuclear pellet and a crude cytosol supernatant fraction. The pellets containing the nuclear proteins were washed twice, dissolved in 0.5ml of 0.3M-NaOH and both radioactivity and DNA content (Burton, 1956) were measured. The supernatant fraction was centrifuged at 39000g for 10min at 40C and the resulting supernatant was used as the cytosol protein after measuring its protein content (Lowry et al., 1951) . Bound and free sterols were separated by a modification of the dextran-coated charcoal assay (Visser et al., 1976 preparedfrom rat tissues. Cytsol was prepared from the epiphyses and diaphyses of newborn and of 50-day-old rat tibiae and from the maternal intestinal mucosa as described above. Portions of cytosol were incubated with 1.2nM-[3H124,25-dihydroxycholecalciferol or 1.2nM-[3HI la,25-dihydroxycholecalciferol in the presence or absence of 100-fold excess of the appropriate non-radioactive vitamin D metabolite, or progesterone or triamcinolone acetonide. Incubation was carried out for 90min at 0°C. Bound and free sterols were separated with dextran-coated charcoal and the specific binding was calculated as described above.
Saturation plot and Scatchard analysis. Portions of cytosol prepared from epiphyses of newborn rat tibiae were incubated with increasing concentrations (0.6-24 nM) of P3H]24,25-dihydroxycholecalciferol with or without a 100-fold excess of the non-radioactive metabolite. Bound and free sterols were separated by dextran-coated charcoal. A saturation plot and Scatchard analysis were obtained from the total and specific binding data.
Sucrose-density-gradient analysis Portions (0.5 ml) of cytosol prepared from the epiphyseal region of newborn rat tibiae were incubated with 1.2 nM-[3H]24,25-dihydroxycholecalciferol in the presence or absence of 100-fold excess of unlabelled 24R,25-dihydroxycholecalciferol for 90min at 0°C. The bound and free sterols were separated by dextran-coated charcoal. Then the supernatant fractions were layered on 5-20% sucrose gradients prepared in 10mM-Tris/HCI buffer, pH 7.4, containing 500 mM-dithiothreitol, 1.5 mM-EGTA and 3 mM-MgCI2. The gradients were centrifuged at 249 000g for 19h at 00C with the use of a Beckman L3-50 ultracentrifuge and an SW 50.1 rotor. Fractions (150s1) were collected from the bottom and counted for radioactivity. Sedimentation coefficients were estimated by comparison with 14C-labelled protein markers (bovine serum albumin, 4.0 S; aldolase, 7.8 S). DEAE-cellulose chromatography Portions (0.5 ml) of cytosol prepared from the epiphyseal region of newborn rat tibiae were incubated with 1.2 nM-[3H]24,25-dihydroxycholecalciferol for 90min at 0°C and then applied to DEAE cellulose columns (0.5g in 2ml of buffer; Whatman DE-52), eluted with a linear salt gradient (0-0.6M-KCI) in buffer (10mM-Tris/HCI, pH7.4, containing 50mM-dithiothreitol, 1.5 mM-EGTA and 3 mM-MgCl2) (Sherman et al., 1978) and fractions (1.4 ml) were collected. Protein content (Bradford, 1976) No binding of [3HI 1, was found in the epiphyses of newborn rat tibiae and only a small amount of binding was detected in the diaphyses of these bones. However, a significant specific 1 a,25-dihydroxycholecalciferol binding was found in cytosol prepared from diaphyses of 50-day-old rat tibia bones ( Table 2 ). The maternal intestinal mucosa contains cytoplasmic and nuclear receptors for 1a,25-dihydroxycholecalciferol as previously described (Tsai & Norman, 1973; Brumbaugh & Haussler, 1974 .
A saturation plot and Scatchard analysis of the specific binding of 24,25-dihydroxycholecalciferol to the cytoplasmic epiphyseal receptor revealed a plateau at l0nM and indicated the presence of a (Kream et al., 1977b) could be identified by sucrose-densitygradient analysis.
DEAE-cellulose column chromatography
The elution profiles of the DEAE-cellulose column chromatography (Fig. 2b) (Weisman et al., 1979) of the chloroform/methanol extract of this complex yielded a single peak of radioactive material coinciding with standard 24R,25-dihydroxycholecalciferol.
Discussion
The data comprise three independent lines of evidence for the existence of a specific high-affinity approx. 3.1 S cytoplasmic receptor for 24,25-dihydroxycholecalciferol in rat developing skeletal tissues. The competition studies also suggest the existence of specific nuclear binding of 24,25-dihydroxycholecalciferol in these tissues. The presence of specific cytoplasmic and nuclear receptors for 24,25-dihydroxycholecalciferol in the epiphyses and diaphyses of newborn rat bone suggests that the developing endochondral bone is a target organ for 24,25-dihydroxycholecalciferol and that this sterol acts as a steroid hormone (O'Malley & Schrader, 1976) . Since the newborn epiphyseal and diaphyseal tissues contain substantial amounts of cartilage and relatively little bone, it is suggested that the chondrocyte is the cell type that contains the receptors for 24,25-dihydroxycholecalciferol. Recent studies that have shown a specific nuclear binding of 24,25-dihydroxycholecalciferol and its effects on DNA polymerase activity and proteoglycan synthesis in cultured growth-plate chondrocytes support this assumption (Corvol et al., 1978 (Corvol et al., , 1980 bone formation (Ornoy et al., 1978; Endo et al., 1980) . Previous studies (Kream et al., 1977a; Manolagas et al., 1979; Mellon & De Luca, 1980) have demonstrated the presence of la,25-dihydroxycholecalciferol receptors in chick endochondral bone and in chick and rat caliaria bones. The present study has shown the existence of specific la,25-dihydroxycholecalciferol binding in cytosol prepared from diaphyses of 50-day-old rat tibia, which are rich in bone cells, but not in cytosol prepared from tibiae of newborn rats. The presence of specific receptors for 24,25-dihydroxycholecalciferol is not exclusive to the rat or to developing skeletal tissues.
